WO2008069938A2 - Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide - Google Patents
Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide Download PDFInfo
- Publication number
- WO2008069938A2 WO2008069938A2 PCT/US2007/024489 US2007024489W WO2008069938A2 WO 2008069938 A2 WO2008069938 A2 WO 2008069938A2 US 2007024489 W US2007024489 W US 2007024489W WO 2008069938 A2 WO2008069938 A2 WO 2008069938A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blending
- blend
- ibuprofen
- mixing
- minutes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL07862281T PL2099432T3 (en) | 2006-12-04 | 2007-11-28 | Method of forming a tablet comprising pre-blend of ibuprofen and silicon dioxide |
CN2007800505822A CN101588793B (en) | 2006-12-04 | 2007-11-28 | Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide |
MX2009005959A MX2009005959A (en) | 2006-12-04 | 2007-11-28 | Method of forming a tablet. |
BRPI0717914-6A BRPI0717914A2 (en) | 2006-12-04 | 2007-11-28 | "METHOD OF FORMING A PILL" |
JP2009539301A JP2010511613A (en) | 2006-12-04 | 2007-11-28 | How to form tablets |
AU2007328390A AU2007328390B2 (en) | 2006-12-04 | 2007-11-28 | Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide |
CA002671420A CA2671420A1 (en) | 2006-12-04 | 2007-11-28 | Method of forming a tablet |
EP07862281A EP2099432B1 (en) | 2006-12-04 | 2007-11-28 | Method of forming a tablet comprising pre-blend of ibuprofen and silicon dioxide |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/633,322 | 2006-12-04 | ||
US11/633,322 US20070077297A1 (en) | 2004-09-30 | 2006-12-04 | Modified release ibuprofen dosage form |
US11/906,303 | 2007-10-01 | ||
US11/906,303 US7749537B2 (en) | 2006-12-04 | 2007-10-01 | Method of forming a tablet |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008069938A2 true WO2008069938A2 (en) | 2008-06-12 |
WO2008069938A3 WO2008069938A3 (en) | 2008-10-09 |
Family
ID=39492797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/024489 WO2008069938A2 (en) | 2006-12-04 | 2007-11-28 | Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide |
Country Status (12)
Country | Link |
---|---|
US (1) | US7749537B2 (en) |
EP (1) | EP2099432B1 (en) |
JP (1) | JP2010511613A (en) |
KR (1) | KR20090090369A (en) |
AU (1) | AU2007328390B2 (en) |
BR (1) | BRPI0717914A2 (en) |
CA (1) | CA2671420A1 (en) |
CO (1) | CO6190600A2 (en) |
MX (1) | MX2009005959A (en) |
PL (1) | PL2099432T3 (en) |
TW (1) | TW200831136A (en) |
WO (1) | WO2008069938A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010132635A1 (en) * | 2009-05-13 | 2010-11-18 | Wyeth Llc | Burst drug release compositions |
WO2013154511A1 (en) * | 2012-04-13 | 2013-10-17 | Mahmut Bilgic | Film tablet formulations comprising dexibuprofen |
EP2983719A4 (en) * | 2013-03-15 | 2017-01-25 | Mylan Inc. | Manufacturing process for effervescent dosage forms |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3150586B1 (en) | 2007-02-23 | 2020-01-08 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
CA2720856C (en) * | 2008-05-02 | 2016-02-02 | Gilead Sciences, Inc. | The use of solid carrier particles to improve the processability of a pharmaceutical agent |
ES2363964B1 (en) | 2009-11-20 | 2012-08-22 | Gp Pharm, S.A. | CAPSULES OF PHARMACEUTICAL ACTIVE PRINCIPLES AND ESTERS OF POLYINSATURATED FATTY ACIDS. |
US20140322386A1 (en) * | 2013-04-24 | 2014-10-30 | Northern Brewer Llc | Beer brewing additive and method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10003757A1 (en) * | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen drug preparation |
WO2006039692A2 (en) * | 2004-09-30 | 2006-04-13 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4609675A (en) * | 1984-08-17 | 1986-09-02 | The Upjohn Company | Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing |
GB8601204D0 (en) | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
DE3669103D1 (en) | 1986-11-14 | 1990-04-05 | Puetter Medice Chem Pharm | MEDICINAL PRODUCT CONTAINING IBUPROFEN. |
US4786503A (en) | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
US4806359A (en) | 1987-04-22 | 1989-02-21 | Mcneilab, Inc. | Iburprofen sustained release matrix and process |
US5200193A (en) | 1987-04-22 | 1993-04-06 | Mcneilab, Inc. | Pharmaceutical sustained release matrix and process |
EP0297866A3 (en) | 1987-07-01 | 1989-12-13 | The Boots Company PLC | Therapeutic agents |
SE463541B (en) | 1987-08-31 | 1990-12-10 | Lejus Medical Ab | GRANULATED PRODUCT TRANSFER OF A MELT OF ITSELF AND THE PROCEDURE FOR ITS PREPARATION |
US4814181A (en) | 1987-09-03 | 1989-03-21 | Alza Corporation | Dosage form comprising fast agent delivery followed by slow agent delivery |
US4916161A (en) | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
US5104648A (en) | 1989-02-02 | 1992-04-14 | Mallinckrodt Specialty Chemicals Company | High ibuprofen content granulations |
US4990535A (en) | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
US5087454A (en) | 1990-07-30 | 1992-02-11 | American Home Products Corporation | Ibuprofen tablet |
JPH069382A (en) | 1992-04-17 | 1994-01-18 | Takeda Chem Ind Ltd | Stabilized solid pharmaceutical preparation and its production |
US5429825A (en) | 1992-06-26 | 1995-07-04 | Mcneil-Ppc, Inc. | Rotomelt granulation |
US5512300A (en) | 1992-09-15 | 1996-04-30 | Warner-Lambert Company | Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms |
GB9603699D0 (en) | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
US6348216B1 (en) | 1996-06-10 | 2002-02-19 | Knoll Pharmaceutical Company | Ibuprofen and narcotic analgesic compositions |
US6361794B1 (en) | 1996-06-12 | 2002-03-26 | Basf Corporation | Method of making ibuprofen and narcotic analgesic composition |
US5830503A (en) * | 1996-06-21 | 1998-11-03 | Andrx Pharmaceuticals, Inc. | Enteric coated diltiazem once-a-day formulation |
CA2231195C (en) | 1996-07-08 | 2003-01-21 | Edward Mendell Co., Inc. | Sustained release matrix for high-dose insoluble drugs |
GB9702392D0 (en) | 1997-02-06 | 1997-03-26 | Boots Co Plc | Therapeutic agents |
US6210710B1 (en) | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
DE69828289T2 (en) | 1997-08-11 | 2005-06-02 | Alza Corp., Mountain View | A sustained-release dosage form |
NZ333474A (en) | 1998-01-02 | 1999-06-29 | Mcneil Ppc Inc | A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat |
US20030153623A1 (en) | 1998-07-22 | 2003-08-14 | Yamanouchi Pharmaceutical Co., Ltd. | Solid preparation containing sparingly soluble NSAIDs |
EP1161941A4 (en) * | 1999-03-15 | 2002-08-28 | Kaken Pharma Co Ltd | Quickly disintegrating tablets and process for producing the same |
CA2386312A1 (en) | 1999-09-29 | 2001-04-05 | R.P. Scherer Technologies, Inc. | Hydrolyzed cellulose granulations of salts of drugs |
WO2001042255A1 (en) * | 1999-12-10 | 2001-06-14 | Glaxo Group Limited | (1R,CIS)-4-(4-AMINO-7H-PYRROLO'2,3-I(D) ! PYRIMIDINE-7-YL)-2-CYCLOPENTENE-1-METHANOL DERIVATIVES AS ANTIVIRAL |
DE10001166A1 (en) | 2000-01-13 | 2001-07-19 | Merckle Gmbh | Fused pyrrole compounds, pharmaceutical compositions containing them and their use |
US6623756B1 (en) | 2000-04-27 | 2003-09-23 | Noveon Ip Holdings Corp. | Directly compressed solid dosage articles |
US20030175349A1 (en) | 2001-01-30 | 2003-09-18 | Council Of Scientific And Industrial Research | Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient |
GB0108930D0 (en) | 2001-04-10 | 2001-05-30 | Boots Co Plc | Therapeutic agents |
GB0113841D0 (en) | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
US6547182B2 (en) * | 2001-07-19 | 2003-04-15 | Aerojet-General Corporation | Solid rocket motor bolted thrust takeout structure |
WO2003017981A1 (en) | 2001-08-29 | 2003-03-06 | Ranbaxy Laboratories Limited | Controlled release formulation of clarithromycin or tinidazol |
US6592901B2 (en) | 2001-10-15 | 2003-07-15 | Hercules Incorporated | Highly compressible ethylcellulose for tableting |
EP1444978A1 (en) | 2001-11-13 | 2004-08-11 | Kyowa Hakko Kogyo Co., Ltd. | Amino acid-containing tablets quickly disintegrating in the oral cavity and process for producing the same |
US6866070B2 (en) | 2002-08-08 | 2005-03-15 | Glen Ellyn Industries Llc | Bag insert and support |
CH693586A8 (en) | 2002-10-14 | 2003-12-15 | Roche Consumer Health Ag | Formulation of ibuprofen sodium. |
US20040096497A1 (en) | 2002-11-19 | 2004-05-20 | Ponder Garratt W. | Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions |
EP1575584A4 (en) | 2002-11-29 | 2006-02-01 | Forest Laboratories | Combination of ibuprofen and oxycodone for acute pain relief |
US20040265378A1 (en) | 2003-06-25 | 2004-12-30 | Yingxu Peng | Method and compositions for producing granules containing high concentrations of biologically active substances |
US20070077297A1 (en) | 2004-09-30 | 2007-04-05 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
JP5026675B2 (en) * | 2005-03-08 | 2012-09-12 | 洋文 竹内 | Tablet and method for producing the same |
DE102005049001A1 (en) * | 2005-10-11 | 2007-04-12 | Basf Ag | Process for the preparation of direct tablet ibuprofen formulations |
-
2007
- 2007-10-01 US US11/906,303 patent/US7749537B2/en not_active Expired - Fee Related
- 2007-11-28 PL PL07862281T patent/PL2099432T3/en unknown
- 2007-11-28 JP JP2009539301A patent/JP2010511613A/en active Pending
- 2007-11-28 MX MX2009005959A patent/MX2009005959A/en active IP Right Grant
- 2007-11-28 AU AU2007328390A patent/AU2007328390B2/en not_active Ceased
- 2007-11-28 KR KR1020097014021A patent/KR20090090369A/en not_active Application Discontinuation
- 2007-11-28 EP EP07862281A patent/EP2099432B1/en not_active Not-in-force
- 2007-11-28 CA CA002671420A patent/CA2671420A1/en not_active Abandoned
- 2007-11-28 WO PCT/US2007/024489 patent/WO2008069938A2/en active Application Filing
- 2007-11-28 BR BRPI0717914-6A patent/BRPI0717914A2/en not_active IP Right Cessation
- 2007-12-04 TW TW096146118A patent/TW200831136A/en unknown
-
2009
- 2009-07-03 CO CO09068966A patent/CO6190600A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10003757A1 (en) * | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen drug preparation |
WO2006039692A2 (en) * | 2004-09-30 | 2006-04-13 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010132635A1 (en) * | 2009-05-13 | 2010-11-18 | Wyeth Llc | Burst drug release compositions |
CN102458375A (en) * | 2009-05-13 | 2012-05-16 | 惠氏有限责任公司 | Burst drug release compositions |
TWI478733B (en) * | 2009-05-13 | 2015-04-01 | Wyeth Llc | Burst drug release compositions |
EP3459530A1 (en) * | 2009-05-13 | 2019-03-27 | Wyeth LLC | Burst drug release compositions |
WO2013154511A1 (en) * | 2012-04-13 | 2013-10-17 | Mahmut Bilgic | Film tablet formulations comprising dexibuprofen |
EP2983719A4 (en) * | 2013-03-15 | 2017-01-25 | Mylan Inc. | Manufacturing process for effervescent dosage forms |
Also Published As
Publication number | Publication date |
---|---|
MX2009005959A (en) | 2010-12-20 |
US7749537B2 (en) | 2010-07-06 |
EP2099432B1 (en) | 2012-11-14 |
BRPI0717914A2 (en) | 2013-11-05 |
US20080131507A1 (en) | 2008-06-05 |
CO6190600A2 (en) | 2010-08-19 |
CA2671420A1 (en) | 2008-06-12 |
KR20090090369A (en) | 2009-08-25 |
TW200831136A (en) | 2008-08-01 |
JP2010511613A (en) | 2010-04-15 |
AU2007328390A1 (en) | 2008-06-12 |
AU2007328390B2 (en) | 2012-11-15 |
WO2008069938A3 (en) | 2008-10-09 |
PL2099432T3 (en) | 2013-04-30 |
EP2099432A2 (en) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101588793B (en) | Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide | |
AU2007328390B2 (en) | Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide | |
JP2002060338A (en) | Directly compressed solid dosage form | |
JP6679495B2 (en) | Immunosuppressant | |
US8652492B2 (en) | Wet granulation using a water sequestering agent | |
BRPI0613611A2 (en) | high concentration drug formulations and dosage forms | |
AU784128B2 (en) | Ibuprofen containing active agent preparation | |
Zhao et al. | The impact of disintegrant type, surfactant, and API properties on the processability and performance of roller compacted formulations of acetaminophen and aspirin | |
AU2003240164A1 (en) | Extended release formulation of divalproex sodium | |
JPS63290818A (en) | Slow release tablet based on high molecular hydroxypropylmethyl cellulose and manufacture | |
WO2009084041A2 (en) | Pharmaceutical compositions of dexibuprofen | |
JPH06305982A (en) | Sustained release tablet | |
WO2013107503A1 (en) | Method for producing cinacalcet compositions for direct tableting | |
JP2002536318A (en) | pH-independent extended release pharmaceutical composition | |
JP2001335469A (en) | Method for producing solid preparation | |
US20100172982A1 (en) | Sustained release formulations of divalproex sodium | |
WO2003011256A1 (en) | Oral controlled release pharmaceutical composition of a prokinetic agent | |
EP2671569B1 (en) | Stable pharmaceutical compositions with fast onset | |
JP4643899B2 (en) | Ibuprofen-containing tablet and method for producing the same | |
JP2004352633A (en) | Magnesium oxide tablet | |
JP2016510787A (en) | Dosage form containing crizotinib | |
EP1140032A1 (en) | A pharmaceutical mixture comprising a profen | |
WO2006025029A2 (en) | Extended release composition of divalproex |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780050582.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07862281 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007862281 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007328390 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2009539301 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2671420 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/005959 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2007328390 Country of ref document: AU Date of ref document: 20071128 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 577943 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4351/DELNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09068966 Country of ref document: CO Ref document number: 1020097014021 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0717914 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090603 |